Examples of using Second-line in English and their translations into Greek
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Financial
-
Official/political
-
Computer
This represents a 75 percent drop in the price of second-line treatment since 2006.
safety of GIOTRIF as second-line treatment for patients with advanced NSCLC of squamous histology was investigated in a randomized open-label global Phase III trial LUX-Lung 8.
Until now, physicians in Europe had only one approved therapy for the second-line treatment of this aggressive and difficult-to-treat cancer.
so-called biological response modifiers, or"biologicals," are the second-line treatment option.
WATCH Antibiotics recommended as first-or second-line treatment for a small number of infections.
Fifty-nine percent received study medicinal product as second or greater than second-line therapy.
Jackson announced that the second-line community was coming home.
then second-line therapy is pursued.
although they may be used as a second-line therapy.
This represents a 75% drop in the price of second-line treatment since 2006.
It is also used with dapsone as a second-line option to prevent Pneumocystis jiroveci pneumonia in people with HIV/AIDS.
It is mainly used for the second-line or third-line treatment of locally advanced
so-called biological response modifiers, or"biologicals," are the second-line treatment option.
The Italian soldiers continued advancing towards the second-line of trenches and succeeded in entering it because most of the defenders were still in the trenches and galleries on the northern slopes of hills 1020 and 1050.
Rosiglitazone was initially authorised as Avandia in the European Union in July 2000 as second-line diabetes type-2 treatment to be used when other treatments have either failed or are unsuitable for a patient.
The safety profile for patients treated with Opdivo was consistent with previously reported findings in second-line NSCLC, and no new safety signals were seen with extended follow-up.
The safety profile for patients treated with nivolumab was consistent with previously reported findings in second-line NSCLC and no new safety signals were seen with extended follow-up.
the prices of two key medicines used in second-line treatment have each fallen by 28 percent over the last year, with the most affordable second-line combination now priced at $303 per year.
in CML patients who received nilotinib as first- or second-line therapy, or confirmed loss of MR4(two consecutive measures separated by at least 4 weeks showing loss of MR4(MR4=BCR-ABL/ABL≤0.01%IS)) in CML.
with the most affordable second-line combination(zidovudine/lamivudine+ atazanavir/ritonavir) now priced at $303 per year.